Merit Medical Systems Inc(MMSI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 35.64 | EPS (ttm) | 2.43 | Insider Own | 2.6% | Shs Outstand | 59.7M | Perf Week | -4.06% |
| Market Cap | 5.16B | Forward P/E | 18.75 | EPS next Y | 7.19% | Insider Trans | -1.56% | Shs Float | 58.2M | Perf Month | -5.09% |
| Enterprise Value | 5.53B | PEG | 2.08 | EPS next Q | 1.04 | Inst Own | 105.5% | Short Float | 5.94% | Perf Quarter | 29.08% |
| Income | 0.15B | P/S | 3.27 | EPS this Y | 12.34% | Inst Trans | 3.96% | Short Ratio | 3.91 | Perf Half Y | 23.39% |
| Sales | 1.58B | P/B | 3.07 | EPS next 5Y | 9.03% | ROA | 5.34% | Short Interest | 3.45M | Perf YTD | -1.89% |
| Book/sh | 28.13 | P/C | 11.45 | EPS past 3/5Y | 18.04% - | ROE | 9.19% | 52W High | -8.74% ($94.75) | Perf Year | -2.61% |
| Cash/sh | 7.55 | P/FCF | 25.41 | Sales past 3/5Y | 9.7% 9.46% | ROIC | 5.85% | 52W Low | 44.74% ($59.74) | Perf 3Y | 35.92% |
| Dividend Est. | - | EV/EBITDA | 16.44 | EPS Y/Y TTM | 20.67% | Gross Margin | 49.43% | Volatility(W/M) | 2.6% 2.05% | Perf 5Y | 20.6% |
| Dividend TTM | - | EV/Sales | 3.5 | Sales Y/Y TTM | 10.51% | Oper. Margin | 12.69% | ATR (14) | 2.13 | Perf 10Y | 257.17% |
| Dividend Ex-Date | - | Quick Ratio | 2.79 | EPS Q/Q | 20.3% | Profit Margin | 9.21% | RSI (14) | 46.14 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.2 | Sales Q/Q | 9.83% | SMA20 | -3.7% ($89.79) | Beta | 0.51 | Target Price | $101.45 |
| Payout | - | Debt/Eq | 0.49 | Earnings | 2026/7/30 | SMA50 | 4.36% ($82.86) | Rel Volume | 0.54 | Prev Close | $87.19 |
| Employees | 7500 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 24.09% 3.36% | SMA200 | 12.79% ($76.66) | Avg Volume(3M) | 0.88M | Price | $86.47 |
| IPO | 1990/5/14 | Option/Short | Yes/Yes | Trades | 8088 | Volume | 481,107 | Change | -0.83% |
Company
MMSI is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 A global medical device company that manufactures single-use medical devices. The company manufactures and sells devices for cardiovascular and peripheral vascular procedures, endoscopes, and single-use medical devices for diagnostic and interventional procedures, and is exposed to recurring demand driven by the growing volume of procedures. It is a specialist company in the single-use medical device sector.
Over the past 1 year, on the higher side
9% below its 1-year high.
MMSI makes money exceptionally well
12.69% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.3% this year.
Tap to view numbers
The price looks about right
Trading at 35.6 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by +35.9% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 105.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $5B.
FAQ
What kind of company is MMSI?
MMSI belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of MMSI?
The market cap of MMSI is approximately $5.2B, ranking 1,363 within its sector.
What is the P/E ratio of MMSI?
MMSI has a P/E ratio of approximately 35.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MMSI?
MMSI has recorded a 52-week high of $94.75 and a low of $59.74.